首页 > 最新文献

International Journal of Surgery Protocols最新文献

英文 中文
RETention of urine After INguinal hernia Elective Repair (RETAINER study I and II). 腹股沟疝选择性修复术后尿潴留(保留研究I和II)。
IF 0.9 Q3 Medicine Pub Date : 2021-04-23 DOI: 10.29337/ijsp.137
Stefanie M Croghan, Christina A Fleming, Helen M Mohan, Deena Harji, Jarlath C Bolger, Jessie A Elliott, Michael Boland, Peter E Lonergan, Patrick Dillon, David M Quinlan, Des C Winter

Purpose: Post-operative urinary retention (POUR) is a well-recognised complication of inguinal hernia repair (IHR). The magnitude of the problem is unclear, and contradictory evidence surrounds postulated risk factors. POUR risks patient distress, catheter-complications and a financial and logistical burden to services. Separately, in the field of IHR, there has been a lack of research into patients' perceptions of surgical 'success'. Our aim is to perform a two-phase, multi-centre prospective study to:Assess the rate, risk factors and impact related to POUR post IH repair.Develop and validate a patient reported outcome measure (PROM) for inguinal hernia repair.

Methods: RETAINER I: We propose a 24-week prospective study with voluntary international participation in 4 week blocks. All patients undergoing elective IH repair (minimally-invasive/open) will be eligible. Standardised data collection will include patient and perioperative factors. Primary outcome will be development of POUR, defined as the need for insertion of a urinary catheter as determined by the treating clinician. Secondary outcomes will be identification of factors predisposing to POUR and the impact of POUR.RETAINER II: A patient reported outcome measure will be developed using representative patient focus groups for item generation, from which an initial questionnaire will be developed and piloted. Validity, reliability, sensitivity and reproducibility will be assessed using the QQ-10 and standard psychometric methodology.

Conclusions: Using an international multicentre collaborative approach will produce the necessary volume of patients, whilst capturing inter-centre variability, to accurately reflect POUR rates and allow analysis of risk factors. This patient pool will provide an excellent opportunity to develop a PROM using appropriate qualitative methodology.

Highlights retainer i & ii protocols: RETAINER (RETention of urine After INguinal hernia Elective Repair) I is a prospective, multicentre, international observational study.RETAINER I aims to explore the incidence of and risk factors for urinary retention following elective inguinal hernia repair.Urinary retention following inguinal hernia repair has a marked impact on patients and creates a significant financial and logistical burden for hospital services.RETAINER II is a prospective, qualitative study, recruiting patients to guide the creation of a patient-reported outcome measure (PROM) for elective inguinal hernia repair.

目的:术后尿潴留(POUR)是腹股沟疝修补术(IHR)的常见并发症。这个问题的严重程度尚不清楚,围绕着假定的风险因素的证据相互矛盾。POUR有患者窘迫、导管并发症以及服务的财政和后勤负担的风险。另外,在《国际卫生条例》领域,缺乏对患者对手术“成功”的看法的研究。我们的目标是进行一项两阶段、多中心的前瞻性研究,以评估IH后POUR修复的发生率、风险因素和影响。开发和验证腹股沟疝修补的患者报告结果测量(PROM)。方法:保留I:我们提出了一项为期24周的前瞻性研究,国际自愿参与,为期4周。所有接受选择性IH修复(微创/开放)的患者都符合条件。标准化的数据收集将包括患者和围手术期因素。主要结局将是尿潴留的发展,定义为由治疗的临床医生确定是否需要插入导尿管。次要结果将是确定诱发POUR的因素和POUR的影响。保留II:将使用具有代表性的患者焦点小组进行项目生成,开发患者报告的结果测量,并从中开发和试点初始问卷。效度、信度、灵敏度和可重复性将使用QQ-10和标准心理测量方法进行评估。结论:采用国际多中心合作方法将产生必要的患者数量,同时捕获中心间的可变性,以准确反映POUR率并允许分析风险因素。这个病人池将提供一个极好的机会,以开发PROM使用适当的定性方法。保留器i和ii方案:保留器(腹股沟疝选择性修复后尿潴留)i是一项前瞻性、多中心、国际观察性研究。retention I旨在探讨选择性腹股沟疝修补术后尿潴留的发生率和危险因素。腹股沟疝修补术后尿潴留对患者有显著影响,并对医院服务造成重大的财政和后勤负担。RETAINER II是一项前瞻性定性研究,招募患者来指导选择性腹股沟疝修补术患者报告结果测量(PROM)的创建。
{"title":"RETention of urine After INguinal hernia Elective Repair (RETAINER study I and II).","authors":"Stefanie M Croghan,&nbsp;Christina A Fleming,&nbsp;Helen M Mohan,&nbsp;Deena Harji,&nbsp;Jarlath C Bolger,&nbsp;Jessie A Elliott,&nbsp;Michael Boland,&nbsp;Peter E Lonergan,&nbsp;Patrick Dillon,&nbsp;David M Quinlan,&nbsp;Des C Winter","doi":"10.29337/ijsp.137","DOIUrl":"https://doi.org/10.29337/ijsp.137","url":null,"abstract":"<p><strong>Purpose: </strong>Post-operative urinary retention (POUR) is a well-recognised complication of inguinal hernia repair (IHR). The magnitude of the problem is unclear, and contradictory evidence surrounds postulated risk factors. POUR risks patient distress, catheter-complications and a financial and logistical burden to services. Separately, in the field of IHR, there has been a lack of research into patients' perceptions of surgical 'success'. Our aim is to perform a two-phase, multi-centre prospective study to:Assess the rate, risk factors and impact related to POUR post IH repair.Develop and validate a patient reported outcome measure (PROM) for inguinal hernia repair.</p><p><strong>Methods: </strong>RETAINER I: We propose a 24-week prospective study with voluntary international participation in 4 week blocks. All patients undergoing elective IH repair (minimally-invasive/open) will be eligible. Standardised data collection will include patient and perioperative factors. Primary outcome will be development of POUR, defined as the need for insertion of a urinary catheter as determined by the treating clinician. Secondary outcomes will be identification of factors predisposing to POUR and the impact of POUR.RETAINER II: A patient reported outcome measure will be developed using representative patient focus groups for item generation, from which an initial questionnaire will be developed and piloted. Validity, reliability, sensitivity and reproducibility will be assessed using the QQ-10 and standard psychometric methodology.</p><p><strong>Conclusions: </strong>Using an international multicentre collaborative approach will produce the necessary volume of patients, whilst capturing inter-centre variability, to accurately reflect POUR rates and allow analysis of risk factors. This patient pool will provide an excellent opportunity to develop a PROM using appropriate qualitative methodology.</p><p><strong>Highlights retainer i & ii protocols: </strong>RETAINER (RETention of urine After INguinal hernia Elective Repair) I is a prospective, multicentre, international observational study.RETAINER I aims to explore the <i>incidence of</i> and <i>risk factors for</i> urinary retention following elective inguinal hernia repair.Urinary retention following inguinal hernia repair has a marked impact on patients and creates a significant financial and logistical burden for hospital services.RETAINER II is a prospective, qualitative study, recruiting patients to guide the creation of a patient-reported outcome measure (PROM) for elective inguinal hernia repair.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial. 评价ReHub在初次全膝关节置换术患者中的安全性和有效性:一项随机对照试验的研究方案。
IF 0.9 Q3 Medicine Pub Date : 2021-04-19 DOI: 10.29337/ijsp.138
Montse Nuevo, Hadis Mahdavi, Daniel Rodríguez, Teresa Faura, Núria Fabrellas, Simone Balocco, Marco Conti, Alessandro Castagna, Salvi Prat

Background: Total Knee Arthroplasty (TKA) is an intervention that can significantly improve the quality of life of patients with advanced knee osteoarthritis. Early start of rehabilitation and its continuation at home once the patient is discharged are key factors for the success of the process.This study aims to assess the effectiveness of a home-based telerehabilitation solution (ReHub) on improving functional capacity and clinical outcomes for patients who underwent TKA.

Methods/design: The study is a randomized, open-label with blinded outcome assessor, parallel assignment clinical trial with a sample size of 52 patients that is conducted according to the SPIRIT recommendations. After the TKA intervention, the patients are randomly allocated to the control group or the experimental group with a 1:1 ratio. Both groups follow a Fast Track recovery protocol which includes discharge after 2-3 days from surgery, a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after surgery. The experimental group uses the sensor-based telerehabilitation system ReHub to perform the exercises. The primary outcome measure is the range of motion of the knee. Secondary outcomes include physical performance, quality of life, pain intensity, muscle strength, treatment adherence and satisfaction with the ReHub system. The outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).The study conforms to the guidelines of the Declaration of Helsinki and was approved by the hospital's ethics committee.

Discussion: The study will address an important gap in the evidence base by reporting the effectiveness of an affordable and low-cost home-based telerehabilitation solution in patients who underwent TKA.

Ethics and dissemination: The study was approved by the hospital's ethics committee ("Comité Ético de Investigación Clínica del HCB", reg. HCB/2019/0571). The trial was registred at ClinicalTrials.gov (NCT04155957). The results of this study will be published in peer-reviewed journals as well as national and international conferences.

Trial registration: NCT04155957 (ClinicalTrials.gov).

Highlights: Assessing a home-based telerehabilitation solution effectiveness in knee surgery.In situations such as the CoVid-19 pandemic, it is a resolutive intervention method.Telerehabilitation is an alternative to conventional face-to-face physical therapy.This system is far less demanding in terms of human resources.Range of motion assessment is the primary outcome measure.

背景:全膝关节置换术(TKA)是一种可以显著改善晚期膝关节骨关节炎患者生活质量的干预措施。患者出院后尽早开始康复并在家中继续康复是康复过程成功的关键因素。本研究旨在评估基于家庭的远程康复解决方案(ReHub)在改善TKA患者功能能力和临床结果方面的有效性。方法/设计:该研究是一项随机、开放标签、盲法结局评估、平行分配临床试验,样本量为52例患者,根据SPIRIT推荐进行。经TKA干预后,将患者按1:1的比例随机分为对照组和实验组。两组患者都遵循快速康复方案,包括术后2-3天后出院,每天5次自主康复锻炼计划,以及术后约2周开始由物理治疗师上门就诊。实验组使用基于传感器的远程康复系统ReHub进行练习。主要的结果测量是膝关节的活动范围。次要结局包括身体表现、生活质量、疼痛强度、肌肉力量、治疗依从性和对ReHub系统的满意度。结果评估在出院(基线)、拆线(基线后2周)和拆线后2周(基线后4周)进行。这项研究符合赫尔辛基宣言的指导方针,并得到了医院伦理委员会的批准。讨论:该研究将通过报告可负担和低成本的家庭远程康复解决方案对接受TKA的患者的有效性来解决证据基础上的一个重要空白。伦理和传播:该研究得到了医院伦理委员会(“comit Ético de Investigación Clínica del HCB”,reg)的批准。六氯苯/ 2019/0571)。该试验已在ClinicalTrials.gov注册(NCT04155957)。这项研究的结果将发表在同行评议的期刊以及国内和国际会议上。试验注册:NCT04155957 (ClinicalTrials.gov)。重点:评估基于家庭的远程康复解决方案在膝关节手术中的有效性。在CoVid-19大流行等情况下,这是一种果断的干预方法。远程康复是传统面对面物理治疗的另一种选择。这种制度对人力资源的要求要低得多。活动范围评估是主要的预后指标。
{"title":"Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial.","authors":"Montse Nuevo,&nbsp;Hadis Mahdavi,&nbsp;Daniel Rodríguez,&nbsp;Teresa Faura,&nbsp;Núria Fabrellas,&nbsp;Simone Balocco,&nbsp;Marco Conti,&nbsp;Alessandro Castagna,&nbsp;Salvi Prat","doi":"10.29337/ijsp.138","DOIUrl":"https://doi.org/10.29337/ijsp.138","url":null,"abstract":"<p><strong>Background: </strong>Total Knee Arthroplasty (TKA) is an intervention that can significantly improve the quality of life of patients with advanced knee osteoarthritis. Early start of rehabilitation and its continuation at home once the patient is discharged are key factors for the success of the process.This study aims to assess the effectiveness of a home-based telerehabilitation solution (ReHub) on improving functional capacity and clinical outcomes for patients who underwent TKA.</p><p><strong>Methods/design: </strong>The study is a randomized, open-label with blinded outcome assessor, parallel assignment clinical trial with a sample size of 52 patients that is conducted according to the SPIRIT recommendations. After the TKA intervention, the patients are randomly allocated to the control group or the experimental group with a 1:1 ratio. Both groups follow a Fast Track recovery protocol which includes discharge after 2-3 days from surgery, a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after surgery. The experimental group uses the sensor-based telerehabilitation system ReHub to perform the exercises. The primary outcome measure is the range of motion of the knee. Secondary outcomes include physical performance, quality of life, pain intensity, muscle strength, treatment adherence and satisfaction with the ReHub system. The outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).The study conforms to the guidelines of the Declaration of Helsinki and was approved by the hospital's ethics committee.</p><p><strong>Discussion: </strong>The study will address an important gap in the evidence base by reporting the effectiveness of an affordable and low-cost home-based telerehabilitation solution in patients who underwent TKA.</p><p><strong>Ethics and dissemination: </strong>The study was approved by the hospital's ethics committee (\"Comité Ético de Investigación Clínica del HCB\", reg. HCB/2019/0571). The trial was registred at ClinicalTrials.gov (NCT04155957). The results of this study will be published in peer-reviewed journals as well as national and international conferences.</p><p><strong>Trial registration: </strong>NCT04155957 (ClinicalTrials.gov).</p><p><strong>Highlights: </strong>Assessing a home-based telerehabilitation solution effectiveness in knee surgery.In situations such as the CoVid-19 pandemic, it is a resolutive intervention method.Telerehabilitation is an alternative to conventional face-to-face physical therapy.This system is far less demanding in terms of human resources.Range of motion assessment is the primary outcome measure.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study. 一种新型混合方法平台研究方案,用于研究新型手术设备,具有嵌入式共享学习:Ibra-net乳房病变定位研究。
IF 0.9 Q3 Medicine Pub Date : 2021-04-16 DOI: 10.29337/ijsp.136
Hannah L Bromley, Rajiv Dave, Chris Holcombe, Shelley Potter, Anthony J Maxwell, Cliona Kirwan, Senthurun Mylvaganam, Suzanne Elgammal, Jenna Morgan, Sue Down, Tahir Masudi, Amtul Sami, Nicola Barnes, James Harvey

Introduction: New medical devices must have adequate research, such that outcomes are known, enabling patients to be consented with knowledge of the safety and efficacy of the device to be implanted. Device trials are challenging due to the learning curve and iterative assessment of best practice. This study is designed to pilot a national collaborative approach to medical device introduction by breast surgeons in the UK, using breast localisation devices as an exemplar. The aim is to develop an effective and transferable surgical device platform protocol design, with embedded shared learning.

Methods and analysis: The iBRA-net localisation study is a UK based prospective, multi-centre platform study, comparing the safety and efficacy of novel localisation devices with wire-guided breast lesion localisation for wide local excision, using Magseed® as the pilot intervention group. Centres performing breast lesion localisation for wide local excision or excision biopsy will be eligible to participate if using one of the included devices. Further intervention arms will be added as new devices are CE marked. Outcomes will be collected via an online database. The primary outcome measure will be identification of the index lesion. Participating surgeons will be asked to record shared learning events via online questionnaires and focus group interviews to inform future study arms.

Ethics and dissemination: The study will aim to collect data on 950 procedures for each intervention (Magseed® and wire localisation) from UK breast centres over an 18-month period. Shared learning will be prospectively evaluated via thematic analysis to refine breast localisation technique and to promote early identification of potential pitfalls and problems. Results will be presented at national and international conferences and published in peer reviewed journals.

Registration: This is a UK national audit registered with Manchester University NHS Foundation Trust.

Highlights: This protocol outlines a novel methodology for a collaborative national platform study to collate safety and efficacy data on new medical devices. Improved registration and audit of new medical devices is a major theme of the Cumberlege report of the Independent Medicines and Medical Devices Safety Review.We outline a protocol for a UK based multi-centre prospective audit to investigate the safety and efficacy of new surgical devices for breast lesion localisation. The study will run as a platform study using wire localisation as a control group and Magseed® as the first intervention arm.The protocol is designed for additional bolt-on intervention arms for other localisation devices, such as Hologic Localizer™ and Savi Scout®, when they become available to the European market. This will enable comparison of these devices to datasets already collected on wire and Magseed® localisation.The stud

导言:新的医疗器械必须有充分的研究,这样的结果是已知的,使患者同意了解植入设备的安全性和有效性。由于学习曲线和最佳实践的迭代评估,设备试验具有挑战性。本研究的目的是试点一个国家合作的方法,以医疗设备引进乳房外科医生在英国,使用乳房定位装置为例。目的是开发一种有效的、可转移的手术器械平台协议设计,并嵌入共享学习。方法和分析:iBRA-net定位研究是一项基于英国的前瞻性,多中心平台研究,比较新型定位装置与线导乳房病变定位的安全性和有效性,用于广泛的局部切除,使用Magseed®作为试点干预组。如果使用其中一种设备,进行乳房病变定位进行广泛局部切除或切除活检的中心将有资格参加。随着新设备获得CE标志,将增加进一步的干预臂。结果将通过在线数据库收集。主要的结果测量将是主要病变的识别。参与的外科医生将被要求通过在线问卷和焦点小组访谈记录共享的学习事件,以告知未来的研究部门。伦理和传播:该研究旨在收集来自英国乳腺中心的950例干预(Magseed®和钢丝定位)的数据,为期18个月。将通过专题分析对共享学习进行前瞻性评估,以改进乳房定位技术,并促进早期识别潜在的陷阱和问题。研究结果将在国内和国际会议上发表,并发表在同行评议的期刊上。注册:这是在曼彻斯特大学NHS基金会信托基金注册的英国国家审计。重点:本协议概述了一种新的方法,用于国家合作平台研究,以整理新医疗器械的安全性和有效性数据。改进新医疗器械的注册和审核是独立药品和医疗器械安全审查的Cumberlege报告的一个主要主题。我们概述了一项基于英国的多中心前瞻性审计的协议,以调查用于乳房病变定位的新手术设备的安全性和有效性。该研究将作为一个平台研究,使用导线定位作为对照组,Magseed®作为第一个干预组。该协议旨在为其他定位设备(如Hologic Localizer™和Savi Scout®)提供额外的螺栓式干预臂,当它们在欧洲市场上市时。这将使这些设备与已经在wire和Magseed®本地化上收集的数据集进行比较。该研究包括一种新的共享学习方法,使用迭代在线数据库报告和外科访谈来集中分发有关学习事件、关键治理问题和未来使用的推荐协议的信息。
{"title":"A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study.","authors":"Hannah L Bromley,&nbsp;Rajiv Dave,&nbsp;Chris Holcombe,&nbsp;Shelley Potter,&nbsp;Anthony J Maxwell,&nbsp;Cliona Kirwan,&nbsp;Senthurun Mylvaganam,&nbsp;Suzanne Elgammal,&nbsp;Jenna Morgan,&nbsp;Sue Down,&nbsp;Tahir Masudi,&nbsp;Amtul Sami,&nbsp;Nicola Barnes,&nbsp;James Harvey","doi":"10.29337/ijsp.136","DOIUrl":"https://doi.org/10.29337/ijsp.136","url":null,"abstract":"<p><strong>Introduction: </strong>New medical devices must have adequate research, such that outcomes are known, enabling patients to be consented with knowledge of the safety and efficacy of the device to be implanted. Device trials are challenging due to the learning curve and iterative assessment of best practice. This study is designed to pilot a national collaborative approach to medical device introduction by breast surgeons in the UK, using breast localisation devices as an exemplar. The aim is to develop an effective and transferable surgical device platform protocol design, with embedded shared learning.</p><p><strong>Methods and analysis: </strong>The iBRA-net localisation study is a UK based prospective, multi-centre platform study, comparing the safety and efficacy of novel localisation devices with wire-guided breast lesion localisation for wide local excision, using Magseed® as the pilot intervention group. Centres performing breast lesion localisation for wide local excision or excision biopsy will be eligible to participate if using one of the included devices. Further intervention arms will be added as new devices are CE marked. Outcomes will be collected via an online database. The primary outcome measure will be identification of the index lesion. Participating surgeons will be asked to record shared learning events via online questionnaires and focus group interviews to inform future study arms.</p><p><strong>Ethics and dissemination: </strong>The study will aim to collect data on 950 procedures for each intervention (Magseed® and wire localisation) from UK breast centres over an 18-month period. Shared learning will be prospectively evaluated via thematic analysis to refine breast localisation technique and to promote early identification of potential pitfalls and problems. Results will be presented at national and international conferences and published in peer reviewed journals.</p><p><strong>Registration: </strong>This is a UK national audit registered with Manchester University NHS Foundation Trust.</p><p><strong>Highlights: </strong>This protocol outlines a novel methodology for a collaborative national platform study to collate safety and efficacy data on new medical devices. Improved registration and audit of new medical devices is a major theme of the Cumberlege report of the Independent Medicines and Medical Devices Safety Review.We outline a protocol for a UK based multi-centre prospective audit to investigate the safety and efficacy of new surgical devices for breast lesion localisation. The study will run as a platform study using wire localisation as a control group and Magseed® as the first intervention arm.The protocol is designed for additional bolt-on intervention arms for other localisation devices, such as Hologic Localizer™ and Savi Scout®, when they become available to the European market. This will enable comparison of these devices to datasets already collected on wire and Magseed® localisation.The stud","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical Effectiveness of Various Surgical Procedures Addressing Long Head of Biceps Pathology: Protocol for a Systematic Review and Meta-Analysis. 治疗肱二头肌长头病变的各种外科手术的临床效果:系统回顾和荟萃分析方案。
IF 0.9 Q3 Medicine Pub Date : 2021-04-13 DOI: 10.29337/ijsp.139
Alexander W Hartland, Raisa Islam, Kar H Teoh, Mustafa S Rashid

Introduction: The long head of biceps tendon is a common source of anterior shoulder pain and impaired function. Multiple surgical procedures are available as treatment options, but the optimal procedure is not known. The aim of this systematic review and meta-analysis is to review the literature to assess the clinical effectiveness of various surgical procedures to treat pain arising from the long head of biceps.

Methods: The study protocol was designed and registered prospectively on PROSPERO (International prospective register for systematic reviews). Electronic databases used for the literature search will include MEDLINE, EMBASE, PsycINFO, and The Cochrane Library. Randomised controlled trials (RCTs) evaluating surgical procedures on the long head of biceps will be included. Our primary outcome is any functional patient-reported outcome measure related to the shoulder. Secondary outcomes will include the rate of 'Popeye' deformity, the rate of biceps cramping pain, the rate of complications, objective measurements of strength testing such as dynamometer, and other patient-reported outcome measures not specific to the shoulder such as the Visual-Analog Scale (VAS) for pain. Methodological quality of included studies will be assessed using The Cochrane Risk of Bias Tool 2.0 and the Jadad score. Inconsistency and bias across included studies will be assessed statistically. Comparable outcome data will be pooled and analysed quantitatively or qualitatively as appropriate.

Ethics and dissemination: No ethical clearances required for this study. We plan to publish this systematic review and meta-analysis in a peer-reviewed journal. It will also be presented at various national and international conferences.

Highlights: Evaluating the clinical effectiveness of surgical procedures for long head of biceps pathology.Randomised controlled trials.Biceps tenodesis and biceps tenotomy.Systematic review compliant with the PRISMA guideline.

简介:二头肌肌腱的长头是肩前疼痛和功能受损的常见原因。多种外科手术可作为治疗选择,但最佳手术尚不清楚。本系统综述和荟萃分析的目的是回顾文献,以评估各种外科手术治疗二头肌长头疼痛的临床效果。方法:设计研究方案,并在PROSPERO(国际前瞻性系统评价注册系统)上进行前瞻性注册。用于文献检索的电子数据库包括MEDLINE、EMBASE、PsycINFO和Cochrane Library。随机对照试验(rct)评估二头肌长头的外科手术程序将包括在内。我们的主要终点是任何功能性患者报告的与肩部相关的终点测量。次要结果将包括“大力水手”畸形率、二头肌痉挛疼痛率、并发症率、力量测试的客观测量,如测力计,以及其他患者报告的非特定于肩部的结果测量,如疼痛的视觉模拟量表(VAS)。纳入研究的方法学质量将使用Cochrane风险偏倚工具2.0和Jadad评分进行评估。纳入研究的不一致性和偏倚将进行统计学评估。将汇集可比较的结果数据,并酌情进行定量或定性分析。伦理与传播:本研究不需要伦理许可。我们计划在同行评议的期刊上发表这一系统综述和荟萃分析。它还将在各种国家和国际会议上发表。重点:评价二头肌长头病变外科手术的临床效果。随机对照试验。二头肌肌腱固定术和二头肌肌腱切断术。系统评审符合PRISMA指南。
{"title":"Clinical Effectiveness of Various Surgical Procedures Addressing Long Head of Biceps Pathology: Protocol for a Systematic Review and Meta-Analysis.","authors":"Alexander W Hartland,&nbsp;Raisa Islam,&nbsp;Kar H Teoh,&nbsp;Mustafa S Rashid","doi":"10.29337/ijsp.139","DOIUrl":"https://doi.org/10.29337/ijsp.139","url":null,"abstract":"<p><strong>Introduction: </strong>The long head of biceps tendon is a common source of anterior shoulder pain and impaired function. Multiple surgical procedures are available as treatment options, but the optimal procedure is not known. The aim of this systematic review and meta-analysis is to review the literature to assess the clinical effectiveness of various surgical procedures to treat pain arising from the long head of biceps.</p><p><strong>Methods: </strong>The study protocol was designed and registered prospectively on PROSPERO (International prospective register for systematic reviews). Electronic databases used for the literature search will include MEDLINE, EMBASE, PsycINFO, and The Cochrane Library. Randomised controlled trials (RCTs) evaluating surgical procedures on the long head of biceps will be included. Our primary outcome is any functional patient-reported outcome measure related to the shoulder. Secondary outcomes will include the rate of 'Popeye' deformity, the rate of biceps cramping pain, the rate of complications, objective measurements of strength testing such as dynamometer, and other patient-reported outcome measures not specific to the shoulder such as the Visual-Analog Scale (VAS) for pain. Methodological quality of included studies will be assessed using The Cochrane Risk of Bias Tool 2.0 and the Jadad score. Inconsistency and bias across included studies will be assessed statistically. Comparable outcome data will be pooled and analysed quantitatively or qualitatively as appropriate.</p><p><strong>Ethics and dissemination: </strong>No ethical clearances required for this study. We plan to publish this systematic review and meta-analysis in a peer-reviewed journal. It will also be presented at various national and international conferences.</p><p><strong>Highlights: </strong>Evaluating the clinical effectiveness of surgical procedures for long head of biceps pathology.Randomised controlled trials.Biceps tenodesis and biceps tenotomy.Systematic review compliant with the PRISMA guideline.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38930286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Factors Associated with Foot Lesions in Diabetic Patients at Saint-Louis Hospital (Senegal): A Case-Control Study Protocol. 圣路易医院(塞内加尔)糖尿病患者足部病变相关因素:病例对照研究方案
IF 0.9 Q3 Medicine Pub Date : 2021-04-09 DOI: 10.29337/ijsp.141
A Ndong, B Konta, J N Tendeng, D G Dia, A D Dia, M L Diao, A C Diallo, S Diop, B M Gouamba, D A Dia, M Diedhiou, M Dieng, M L Fall, P M Ma Nyemb, I Konaté

Introduction: Diabetes prevalence has increased over the past years. In Senegal, this prevalence is 4% in the general population. However, the region of Saint-Louis (in the north of the country) has the highest rate with 10.4%. The main prognosis problem is the occurrence foot lesions that can lead to lower-limbs amputation. Diabetic foot is a real public health issue, due to its economic burden and its serious repercussions on patients, leading to poor quality of life. The objective of this case-control study is to identify factors associated with foot lesions in diabetic patients.

Methods and analysis: It will be a case-control study from January to December 2021. The patients will be recruited from the departments of general surgery, internal medicine, and emergency. An univariate then multivariate analysis (logistic regression) will allow us to select the variables associated with foot lesions in our study population. The parameters included in the logistic regression will be those with a p < 0.20 in the univariate analysis. Finally, a binary logistic regression analysis (with the calculation of Odds Ratios (OR) with confidence intervals (CI)) according to the backward stepwise method will identify the factors independently associated to foot lesions in diabetic patients.

Ethics and dissemination: This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of factors causing diabetic foot will help to communicate with policymakers to raise the awareness in our community. Finally, it will help to prevent lower limb amputations.

Highlights: Diabetes is the leading cause of non-traumatic lower-limb amputation in the world.The region of Saint-Louis (Senegal) has the highest prevalence of diabetes.Controlling factors associated with foot lesions in diabetic patients can prevent from amputation.

导读:糖尿病患病率在过去几年有所增加。在塞内加尔,这一患病率在一般人群中为4%。然而,圣路易地区(在该国北部)的比例最高,为10.4%。主要的预后问题是发生足部病变,可导致下肢截肢。糖尿病足是一个真正的公共卫生问题,因为它的经济负担和对患者的严重影响,导致生活质量差。本病例对照研究的目的是确定与糖尿病患者足部病变相关的因素。方法与分析:2021年1月- 12月为病例对照研究。患者将从普外科、内科和急诊科招募。单变量和多变量分析(逻辑回归)将允许我们在研究人群中选择与足部病变相关的变量。逻辑回归的参数将是单变量分析中p < 0.20的参数。最后,根据后向逐步法进行二元logistic回归分析(计算比值比(OR)和置信区间(CI)),确定与糖尿病患者足部病变独立相关的因素。伦理与传播:本研究方案将提交本机构伦理委员会批准。了解导致糖尿病足的因素将有助于与决策者沟通,以提高我们社区的认识。最后,它将有助于防止下肢截肢。重点:糖尿病是世界上非创伤性下肢截肢的主要原因。圣路易(塞内加尔)地区的糖尿病患病率最高。糖尿病患者足部病变的控制因素可预防截肢。
{"title":"Factors Associated with Foot Lesions in Diabetic Patients at Saint-Louis Hospital (Senegal): A Case-Control Study Protocol.","authors":"A Ndong,&nbsp;B Konta,&nbsp;J N Tendeng,&nbsp;D G Dia,&nbsp;A D Dia,&nbsp;M L Diao,&nbsp;A C Diallo,&nbsp;S Diop,&nbsp;B M Gouamba,&nbsp;D A Dia,&nbsp;M Diedhiou,&nbsp;M Dieng,&nbsp;M L Fall,&nbsp;P M Ma Nyemb,&nbsp;I Konaté","doi":"10.29337/ijsp.141","DOIUrl":"https://doi.org/10.29337/ijsp.141","url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes prevalence has increased over the past years. In Senegal, this prevalence is 4% in the general population. However, the region of Saint-Louis (in the north of the country) has the highest rate with 10.4%. The main prognosis problem is the occurrence foot lesions that can lead to lower-limbs amputation. Diabetic foot is a real public health issue, due to its economic burden and its serious repercussions on patients, leading to poor quality of life. The objective of this case-control study is to identify factors associated with foot lesions in diabetic patients.</p><p><strong>Methods and analysis: </strong>It will be a case-control study from January to December 2021. The patients will be recruited from the departments of general surgery, internal medicine, and emergency. An univariate then multivariate analysis (logistic regression) will allow us to select the variables associated with foot lesions in our study population. The parameters included in the logistic regression will be those with a p < 0.20 in the univariate analysis. Finally, a binary logistic regression analysis (with the calculation of Odds Ratios (OR) with confidence intervals (CI)) according to the backward stepwise method will identify the factors independently associated to foot lesions in diabetic patients.</p><p><strong>Ethics and dissemination: </strong>This research protocol will be submitted to the Ethics Committee of our institution for approval. The knowledge of factors causing diabetic foot will help to communicate with policymakers to raise the awareness in our community. Finally, it will help to prevent lower limb amputations.</p><p><strong>Highlights: </strong>Diabetes is the leading cause of non-traumatic lower-limb amputation in the world.The region of Saint-Louis (Senegal) has the highest prevalence of diabetes.Controlling factors associated with foot lesions in diabetic patients can prevent from amputation.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial. 微创经胸食管切除术吻合口处先发制人的腔内负压治疗(海绵前试验):一项多中心随机对照试验的研究方案
IF 0.9 Q3 Medicine Pub Date : 2021-03-18 DOI: 10.29337/ijsp.24
Philip C Müller, Diana Vetter, Joshua R Kapp, Christoph Gubler, Bernhard Morell, Dimitri A Raptis, Christian A Gutschow

Introduction: Anastomotic leakage (AL) accounts for a significant proportion of morbidity following oesophagectomy. Endoluminal negative pressure (ENP) therapy via a specifically designed polyurethane foam (EsoSponge®, B.Braun Medical, Melsungen, Germany) has become the standard of care for AL in many specialized centres. The prophylactic (pENP) application of this technique aims to reduce postoperative morbidity and is a novel approach which has not yet been investigated in a prospective study. The aim of this study is therefore to assess the effect of pENP at the anastomotic site in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy.

Methods and analysis: The study design is a prospective, multi-centre, two-arm, parallel-group, randomised controlled trial and will be conducted in two phases. Phase one is a randomised feasibility and safety pilot trial involving 40 consecutive patients. After definitive sample size calculation, additional patients will be included accordingly during phase two. The primary outcome of the study will be the postoperative length of hospitalization until reaching previously defined "fit for discharge criteria". Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed.

Ethics and dissemination: The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with ClinicalTrials.gov on 14.11.2019 (NCT04162860) and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences.

前言:吻合口漏(AL)在食管切除术后的发病率中占相当大的比例。通过专门设计的聚氨酯泡沫(EsoSponge®,B.Braun Medical, Melsungen, Germany)进行腔内负压(ENP)治疗已成为许多专业中心治疗AL的标准方法。该技术的预防性(pENP)应用旨在减少术后发病率,是一种尚未在前瞻性研究中进行调查的新方法。因此,本研究的目的是评估微创经胸Ivor Lewis食管切除术高危患者吻合口处pENP的效果。方法与分析:本研究设计为前瞻性、多中心、双臂、平行组、随机对照试验,将分为两个阶段进行。第一阶段是一项随机可行性和安全性试点试验,涉及40名连续患者。在确定样本量计算后,将在第二阶段纳入相应的额外患者。该研究的主要结果将是术后住院时间,直到达到先前定义的“适合出院标准”。次要结局包括术后发病率、死亡率和术后90天随访的al率。将进行基于意向治疗的确认性分析。伦理和传播:苏黎世大学伦理委员会批准了这项研究(2019-00562),该研究已于2019年11月14日在ClinicalTrials.gov (NCT04162860)和瑞士国家临床试验门户网站(SNCTP000003524)注册。这项研究的结果将在适当的会议上发表和提出。
{"title":"Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial.","authors":"Philip C Müller,&nbsp;Diana Vetter,&nbsp;Joshua R Kapp,&nbsp;Christoph Gubler,&nbsp;Bernhard Morell,&nbsp;Dimitri A Raptis,&nbsp;Christian A Gutschow","doi":"10.29337/ijsp.24","DOIUrl":"https://doi.org/10.29337/ijsp.24","url":null,"abstract":"<p><strong>Introduction: </strong>Anastomotic leakage (AL) accounts for a significant proportion of morbidity following oesophagectomy. Endoluminal negative pressure (ENP) therapy via a specifically designed polyurethane foam (EsoSponge<sup>®</sup>, B.Braun Medical, Melsungen, Germany) has become the standard of care for AL in many specialized centres. The prophylactic (pENP) application of this technique aims to reduce postoperative morbidity and is a novel approach which has not yet been investigated in a prospective study. The aim of this study is therefore to assess the effect of pENP at the anastomotic site in high-risk patients undergoing minimally invasive transthoracic Ivor Lewis oesophagectomy.</p><p><strong>Methods and analysis: </strong>The study design is a prospective, multi-centre, two-arm, parallel-group, randomised controlled trial and will be conducted in two phases. Phase one is a randomised feasibility and safety pilot trial involving 40 consecutive patients. After definitive sample size calculation, additional patients will be included accordingly during phase two. The primary outcome of the study will be the postoperative length of hospitalization until reaching previously defined \"fit for discharge criteria\". Secondary outcomes will include postoperative morbidity, mortality and postoperative AL-rates based on 90-day follow-up. A confirmatory analysis based on intention-to-treat will be performed.</p><p><strong>Ethics and dissemination: </strong>The ethics committee of the University of Zurich approved this study (2019-00562), which has been registered with <i>ClinicalTrials.gov</i> on 14.11.2019 (NCT04162860) and the Swiss National Clinical Trials Portal (SNCTP000003524). The results of the study will be published and presented at appropriate conferences.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Outcomes of Hip Arthroscopy in Patients with Femoroacetabular Impingement and Concomitant Tönnis Grade II Osteoarthritis or Greater: Protocol for a Systematic Review. 髋关节镜治疗股髋臼撞击合并Tönnis II级或以上骨关节炎的结果:系统评价方案
IF 0.9 Q3 Medicine Pub Date : 2021-03-16 DOI: 10.29337/ijsp.26
Octavian Andronic, Leica Claydon, Rachael Cubberley, Karadi Hari Sunil-Kumar, Vikas Khanduja

Introduction: Outcomes of hip arthroscopy for femoroacetabular impingement and concomitant moderate- to advanced hip osteoarthritis (Tönnis Grade II or greater) is still a matter of debate as findings in the literature are controversial. This study aims to investigate whether hip arthroscopy is effective in treating patients with femoroacetabular impingement and Tönnis hip osteoarthritis Grade II or greater.

Methods and analysis: The protocol follows the PRISMA-P guidelines. The systematic review is registered in the International Prospective Register for Systematic Reviews and Meta-analysis (PROSPERO) under the registration number: CRD42020210936. The search will include multiple databases: MEDLINE, EMBASE, Web of Science Core Collection and Cochrane library. The screening and selection process will be performed by two independent researchers based on predefined criteria. All studies published in English or German from inception to 1st of December 2020 that investigated outcomes of hip arthroscopy in patients with Tönnis grade II or greater of hip osteoarthritis will be considered eligible. The risk of bias and quality of articles will be assessed using the MINORS tool. Methodological inconsistency and heterogeneity will be explored using the I2 test. This assessment will be used to provide recommendations using the GRADE system.

Ethics and dissemination: Separate ethical approval is not required. This study will be a comprehensive and rigorous systematic review on all published articles reporting on outcomes of hip arthroscopy for femoroacetabular impingement and concomitant hip osteoarthritis Tönnis Grade II or greater. It will explore patient reported outcomes as well as radiological outcomes, complications, rates of revision surgery and rates of conversion to total hip replacement (THR). Results of the current review will be published in a peer-reviewed scientific journal and disseminated on research platforms according to copyright rules and rights.

Highlights: Hip arthroscopy is used to treat femoroacetabular impingement and is effective in patients that have concomitant hip osteoarthritis Tönnis Grade 0 or 1.Outcomes of hip arthroscopy in patients with femoroacetabular impingement and in moderate to advanced osteoarthritis - Tönnis Grade 2 or greater, is a matter of debate.The purpose of the current systematic review is to elucidate, stratify and critical appraise the current evidence on outcomes in this patient subpopulation.

导读:髋关节镜治疗股髋臼撞击并伴有中晚期髋关节骨关节炎(Tönnis II级或以上)的结果仍然是一个有争议的问题,因为文献中的发现是有争议的。本研究旨在探讨髋关节镜治疗股髋臼撞击合并Tönnis II级及以上髋关节骨性关节炎患者是否有效。方法和分析:该方案遵循PRISMA-P指南。该系统评价已在国际前瞻性系统评价和荟萃分析注册(PROSPERO)中注册,注册号为CRD42020210936。搜索将包括多个数据库:MEDLINE, EMBASE, Web of Science Core Collection和Cochrane library。筛选和选择过程将由两名独立的研究人员根据预先确定的标准进行。从开始到2020年12月1日,所有以英语或德语发表的研究调查Tönnis II级或以上髋关节骨关节炎患者髋关节镜检查结果的研究将被认为符合条件。偏倚风险和文章质量将使用未成年人工具进行评估。方法学上的不一致和异质性将使用I2检验进行探讨。该评估将用于使用GRADE系统提供建议。伦理和传播:不需要单独的伦理批准。本研究将对所有已发表的关于髋关节镜治疗股髋臼撞击和伴发髋关节骨性关节炎Tönnis II级或以上的结果的文章进行全面、严格的系统综述。它将探讨患者报告的结果以及放射学结果、并发症、翻修手术率和转换为全髋关节置换术(THR)的率。本次评审的结果将在同行评审的科学期刊上发表,并根据版权规则和权利在研究平台上传播。重点:髋关节镜用于治疗股髋臼撞击,对伴有髋关节骨性关节炎Tönnis 0级或1级的患者有效。股骨髋臼撞击和中晚期骨关节炎(Tönnis 2级或以上)患者的髋关节镜检查结果存在争议。本系统综述的目的是阐明、分层和批判性评价该患者亚群的结果的现有证据。
{"title":"Outcomes of Hip Arthroscopy in Patients with Femoroacetabular Impingement and Concomitant Tönnis Grade II Osteoarthritis or Greater: Protocol for a Systematic Review.","authors":"Octavian Andronic,&nbsp;Leica Claydon,&nbsp;Rachael Cubberley,&nbsp;Karadi Hari Sunil-Kumar,&nbsp;Vikas Khanduja","doi":"10.29337/ijsp.26","DOIUrl":"https://doi.org/10.29337/ijsp.26","url":null,"abstract":"<p><strong>Introduction: </strong>Outcomes of hip arthroscopy for femoroacetabular impingement and concomitant moderate- to advanced hip osteoarthritis (Tönnis Grade II or greater) is still a matter of debate as findings in the literature are controversial. This study aims to investigate whether hip arthroscopy is effective in treating patients with femoroacetabular impingement and Tönnis hip osteoarthritis Grade II or greater.</p><p><strong>Methods and analysis: </strong>The protocol follows the PRISMA-P guidelines. The systematic review is registered in the International Prospective Register for Systematic Reviews and Meta-analysis (PROSPERO) under the registration number: CRD42020210936. The search will include multiple databases: MEDLINE, EMBASE, Web of Science Core Collection and Cochrane library. The screening and selection process will be performed by two independent researchers based on predefined criteria. All studies published in English or German from inception to 1<sup>st</sup> of December 2020 that investigated outcomes of hip arthroscopy in patients with Tönnis grade II or greater of hip osteoarthritis will be considered eligible. The risk of bias and quality of articles will be assessed using the MINORS tool. Methodological inconsistency and heterogeneity will be explored using the I<sup>2</sup> test. This assessment will be used to provide recommendations using the GRADE system.</p><p><strong>Ethics and dissemination: </strong>Separate ethical approval is not required. This study will be a comprehensive and rigorous systematic review on all published articles reporting on outcomes of hip arthroscopy for femoroacetabular impingement and concomitant hip osteoarthritis Tönnis Grade II or greater. It will explore patient reported outcomes as well as radiological outcomes, complications, rates of revision surgery and rates of conversion to total hip replacement (THR). Results of the current review will be published in a peer-reviewed scientific journal and disseminated on research platforms according to copyright rules and rights.</p><p><strong>Highlights: </strong>Hip arthroscopy is used to treat femoroacetabular impingement and is effective in patients that have concomitant hip osteoarthritis Tönnis Grade 0 or 1.Outcomes of hip arthroscopy in patients with femoroacetabular impingement and in moderate to advanced osteoarthritis - Tönnis Grade 2 or greater, is a matter of debate.The purpose of the current systematic review is to elucidate, stratify and critical appraise the current evidence on outcomes in this patient subpopulation.</p>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2021-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38918217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Adult cardiac surgical cost variation around the world: Protocol for a systematic review 世界各地成人心脏手术费用变化:系统评价方案
IF 0.9 Q3 Medicine Pub Date : 2020-01-01 DOI: 10.1016/j.isjp.2020.07.004
Dominique Vervoort , Camila R. Guetter , Lena Trager , Priyansh Shah , Carlos Eduardo Diaz-Castrillon , Eric W. Etchill , Rawn Salenger

Introduction

Globally, over one million cardiac operations occur each year, whereas cardiac surgery is expensive and largely inaccessible without insurance or philanthropic support. Substantial cost variation has been reported within cardiac surgery in the United States and among non-cardiac surgical procedures globally, but little is known on the global procedural cost variation for common adult cardiac surgical procedures.

Objectives and significance

This review seeks to assess variation in procedural costs of coronary artery bypass grafting (CABG), mitral valve repair, mitral valve replacement, aortic valve repair, aortic valve replacement, and combined CABG-mitral or CABG-aortic valve procedures between and within countries. Results may give insights in the scope and drivers of cost variation around the world, posing cost reduction lessons. Results may further inform the potential of economies of scale in reducing procedural costs, benefiting patients, hospitals, governments, and insurers.

Methods and analysis

A systematic review will be performed using the EconLit, Embase, PubMed/MEDLINE, Web of Science, and WHO Global Index Medicus databases to identify articles published between January 1, 2000 and June 1, 2020. Studies describing procedural costs for CABG, mitral valve repair, mitral valve replacement, aortic valve repair, aortic valve replacement, and combined CABG-mitral or CABG-aortic valve procedures will be identified. Articles describing other types of cardiac surgery, concomitant aortic surgery, only describing costs related to non-surgical care, or with incomplete cost data will be excluded from the analysis. No exclusion will be based solely on article type or language. Identified costs will be converted to 2019 USD to account for local currency unit inflation and exchange fluctuations.

Ethics and dissemination

This study protocol has been prospectively registered on the International Platform of Registered Systematic Review and Meta-analysis Protocols. This review requires no institutional review board approval. Results of this study will be summarized and disseminated in a peer-review journal.

在全球范围内,每年有超过100万例心脏手术,而心脏手术是昂贵的,而且在没有保险或慈善支持的情况下,大部分人无法进行心脏手术。据报道,美国心脏手术和全球非心脏手术的成本差异很大,但对普通成人心脏手术的全球成本差异知之甚少。目的和意义本综述旨在评估各国之间冠状动脉旁路移植术(CABG)、二尖瓣修复、二尖瓣置换术、主动脉瓣修复、主动脉瓣置换术以及冠状动脉-二尖瓣或冠状动脉-主动脉瓣联合手术的手术成本差异。结果可能会对世界各地成本变化的范围和驱动因素提供见解,提出降低成本的经验教训。结果可能进一步说明规模经济在降低程序成本方面的潜力,使患者、医院、政府和保险公司受益。方法和分析将使用EconLit、Embase、PubMed/MEDLINE、Web of Science和WHO Global Index Medicus数据库进行系统评价,以确定2000年1月1日至2020年6月1日期间发表的文章。研究将描述冠状动脉搭桥、二尖瓣修复、二尖瓣置换术、主动脉瓣修复、主动脉瓣置换术以及冠状动脉搭桥-二尖瓣或冠状动脉搭桥-主动脉瓣联合手术的手术成本。描述其他类型心脏手术、合并主动脉手术、仅描述与非手术护理相关的费用或费用数据不完整的文章将被排除在分析之外。排除将不会仅仅基于文章类型或语言。已确定的费用将转换为2019年美元,以考虑当地货币单位通货膨胀和汇率波动。伦理和传播本研究方案已在国际系统评价和荟萃分析方案注册平台上前瞻性注册。这项审查不需要机构审查委员会的批准。本研究结果将在同行评议期刊上进行总结和传播。
{"title":"Adult cardiac surgical cost variation around the world: Protocol for a systematic review","authors":"Dominique Vervoort ,&nbsp;Camila R. Guetter ,&nbsp;Lena Trager ,&nbsp;Priyansh Shah ,&nbsp;Carlos Eduardo Diaz-Castrillon ,&nbsp;Eric W. Etchill ,&nbsp;Rawn Salenger","doi":"10.1016/j.isjp.2020.07.004","DOIUrl":"10.1016/j.isjp.2020.07.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Globally, over one million cardiac operations occur each year, whereas cardiac surgery is expensive and largely inaccessible without insurance or philanthropic support. Substantial cost variation has been reported within cardiac surgery in the United States and among non-cardiac surgical procedures globally, but little is known on the global procedural cost variation for common adult cardiac surgical procedures.</p></div><div><h3>Objectives and significance</h3><p>This review seeks to assess variation in procedural costs of coronary artery bypass grafting (CABG), mitral valve repair, mitral valve replacement, aortic valve repair, aortic valve replacement, and combined CABG-mitral or CABG-aortic valve procedures between and within countries. Results may give insights in the scope and drivers of cost variation around the world, posing cost reduction lessons. Results may further inform the potential of economies of scale in reducing procedural costs, benefiting patients, hospitals, governments, and insurers.</p></div><div><h3>Methods and analysis</h3><p>A systematic review will be performed using the EconLit, Embase, PubMed/MEDLINE, Web of Science, and WHO Global Index Medicus databases to identify articles published between January 1, 2000 and June 1, 2020. Studies describing procedural costs for CABG, mitral valve repair, mitral valve replacement, aortic valve repair, aortic valve replacement, and combined CABG-mitral or CABG-aortic valve procedures will be identified. Articles describing other types of cardiac surgery, concomitant aortic surgery, only describing costs related to non-surgical care, or with incomplete cost data will be excluded from the analysis. No exclusion will be based solely on article type or language. Identified costs will be converted to 2019 USD to account for local currency unit inflation and exchange fluctuations.</p></div><div><h3>Ethics and dissemination</h3><p>This study protocol has been prospectively registered on the International Platform of Registered Systematic Review and Meta-analysis Protocols. This review requires no institutional review board approval. Results of this study will be summarized and disseminated in a peer-review journal.</p></div>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.isjp.2020.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38269949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRC COVID: Colorectal cancer services during COVID-19 pandemic. Study protocol for service evaluation CRC COVID: COVID-19大流行期间的结直肠癌服务。服务评估的研究方案
IF 0.9 Q3 Medicine Pub Date : 2020-01-01 DOI: 10.1016/j.isjp.2020.07.005
Alona Courtney , Ann-Marie Howell , Najib Daulatzai , Nicos Savva , Oliver Warren , Sarah Mills , Shahnawaz Rasheed , Goel Milind , Nicholas Tekkis , Matthew Gardiner , Tinglong Dai , Bashar Safar , Jonathan E Efron , Ara Darzi , Paris Tekkis , Christos Kontovounisios

Introduction

COVID-19 has had an impact on the provision of colorectal cancer care. The aim of the CRC COVID study is to describe the changes in colorectal cancer services in the UK and USA in response to the pandemic and to understand the long-term impact.

Methods and analysis

This study comprises 4 phases. Phase 1 is a survey of colorectal units that aims to evaluate adherences and deviations from the best practice guidelines during the COVID-19 pandemic. Phase 2 is a monthly prospective data collection of service provision that aims to determine the impact of the service modifications on the long-term cancer specific outcomes compared to the national standards. Phase 3 aims to predict costs attributable to the modifications of the CRC services and additional resources required to treat patients whose treatment has been affected by the pandemic. Phase 4 aims to compare the impact of COVID-19 on the NHS and USA model of healthcare in terms of service provision and cost, and to propose a standardised model of delivering colorectal cancer services for future outbreaks.

Ethics and dissemination

This study is a service evaluation and does not require HRA Approval or Ethical Approval in the UK. Local service evaluation registration is required for each participating centre. In the USA, Ethical Approval was granted by the Research and Development Committee. The results of this study will be disseminated to stakeholders, submitted for peer review publications, conference presentations and circulated via social media.

Registration details

Nil.

covid -19对结直肠癌护理的提供产生了影响。CRC COVID研究的目的是描述英国和美国应对大流行的结直肠癌服务的变化,并了解其长期影响。方法与分析本研究分为四个阶段。第一阶段是对结直肠单位的调查,旨在评估在COVID-19大流行期间遵守和偏离最佳实践指南的情况。第二阶段是每月收集服务提供的前瞻性数据,旨在确定与国家标准相比,服务修改对长期癌症特定结果的影响。第三阶段的目的是预测由于CRC服务的改变而产生的费用,以及治疗受大流行影响的患者所需的额外资源。第4阶段旨在比较COVID-19对NHS和美国医疗保健模式在服务提供和成本方面的影响,并提出一种为未来疫情提供结直肠癌服务的标准化模式。伦理和传播本研究是一项服务评估,在英国不需要HRA批准或伦理批准。每个参与中心都需要进行本地服务评估注册。在美国,研究与发展委员会批准了伦理批准。这项研究的结果将分发给利益相关者,提交同行评审出版物、会议报告,并通过社交媒体传播。登记detailsNil。
{"title":"CRC COVID: Colorectal cancer services during COVID-19 pandemic. Study protocol for service evaluation","authors":"Alona Courtney ,&nbsp;Ann-Marie Howell ,&nbsp;Najib Daulatzai ,&nbsp;Nicos Savva ,&nbsp;Oliver Warren ,&nbsp;Sarah Mills ,&nbsp;Shahnawaz Rasheed ,&nbsp;Goel Milind ,&nbsp;Nicholas Tekkis ,&nbsp;Matthew Gardiner ,&nbsp;Tinglong Dai ,&nbsp;Bashar Safar ,&nbsp;Jonathan E Efron ,&nbsp;Ara Darzi ,&nbsp;Paris Tekkis ,&nbsp;Christos Kontovounisios","doi":"10.1016/j.isjp.2020.07.005","DOIUrl":"10.1016/j.isjp.2020.07.005","url":null,"abstract":"<div><h3>Introduction</h3><p>COVID-19 has had an impact on the provision of colorectal cancer care. The aim of the CRC COVID study is to describe the changes in colorectal cancer services in the UK and USA in response to the pandemic and to understand the long-term impact.</p></div><div><h3>Methods and analysis</h3><p>This study comprises 4 phases. Phase 1 is a survey of colorectal units that aims to evaluate adherences and deviations from the best practice guidelines during the COVID-19 pandemic. Phase 2 is a monthly prospective data collection of service provision that aims to determine the impact of the service modifications on the long-term cancer specific outcomes compared to the national standards. Phase 3 aims to predict costs attributable to the modifications of the CRC services and additional resources required to treat patients whose treatment has been affected by the pandemic. Phase 4 aims to compare the impact of COVID-19 on the NHS and USA model of healthcare in terms of service provision and cost, and to propose a standardised model of delivering colorectal cancer services for future outbreaks.</p></div><div><h3>Ethics and dissemination</h3><p>This study is a service evaluation and does not require HRA Approval or Ethical Approval in the UK. Local service evaluation registration is required for each participating centre. In the USA, Ethical Approval was granted by the Research and Development Committee. The results of this study will be disseminated to stakeholders, submitted for peer review publications, conference presentations and circulated via social media.</p></div><div><h3>Registration details</h3><p>Nil.</p></div>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.isjp.2020.07.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38295734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol B-MaP-C研究:COVID-19大流行期间乳腺癌管理途径研究协议
IF 0.9 Q3 Medicine Pub Date : 2020-01-01 DOI: 10.1016/j.isjp.2020.07.003
Alona Courtney , Rachel O'Connell , Tim Rattay , Baek Kim , Ramsey I. Cutress , Cliona C. Kirwan , Ashu Gandhi , Patricia Fairbrother , Nisha Sharma , Christopher W.J. Cartlidge , Kieran Horgan , Stuart A. McIntosh , Daniel R. Leff , Raghavan Vidya , Shelley Potter , Chris Holcombe , Ellen Copson , Charlotte E. Coles , Rajiv V. Dave

Introduction

Approximately 55,000 women in the United Kingdom are diagnosed with new breast cancer annually. Since emerging in December 2019, SARS-CoV-2 (coronavirus disease 2019, COVID-19) has become a global pandemic, affecting healthcare delivery worldwide. In response to the pandemic, multiple guidelines were issued to assist with rationalising breast cancer care. The primary aim of the B-MaP-C study is to audit and describe breast cancer management of patients newly diagnosed with breast cancer during the COVID-19 pandemic against pre-COVID-19 management practice in the UK. The implications of changes to management will be determined and the impact of a COVID-19 diagnosis on the patient’s breast cancer management will be determined.

Methods and analysis

This is a multi-centre collaborative audit of consecutive breast cancer patients undergoing treatment decisions during the acute and recovery phases of the COVID-19 pandemic. All patients with newly diagnosed primary breast cancer, whose treatment was decided in a multidisciplinary meeting from the 16th March 2020, are eligible for inclusion.

Ethics and dissemination

As this is an audit ethical approval is not required. Each participating centre is required to register the study locally and obtain local governance approvals prior to commencement of data collection. Local audit data will be available to individual participating units for governance purposes. The results of the data analysis will be submitted for publication, as well as disseminated via the ABS newsletter and a webinar. All data will be presented at national and international conferences, circumstances permitting.

Registration details

Each participating centre received local governance audit registration.

在英国,每年大约有55,000名女性被诊断为新发乳腺癌。自2019年12月出现以来,SARS-CoV-2(2019冠状病毒病,COVID-19)已成为全球大流行,影响了全球的医疗保健服务。为应对这一流行病,发布了多项准则,以协助使乳腺癌护理合理化。B-MaP-C研究的主要目的是审计和描述在2019冠状病毒病大流行期间新诊断为乳腺癌的患者的乳腺癌管理与英国COVID-19前的管理实践。将确定管理变化的影响,并确定COVID-19诊断对患者乳腺癌管理的影响。方法和分析这是一项对2019冠状病毒病大流行急性期和恢复期连续接受治疗决策的乳腺癌患者的多中心协作审计。所有在2020年3月16日起的多学科会议上决定治疗的新诊断原发性乳腺癌患者都有资格纳入研究。道德和传播由于这是审计,不需要道德批准。每个参与中心都必须在当地注册研究,并在开始数据收集之前获得当地政府的批准。本地审计数据将提供给各个参与单位用于治理目的。数据分析的结果将提交出版,并通过ABS通讯和网络研讨会进行传播。如果情况允许,所有数据将在国家和国际会议上提交。各参与中心已接受本地管治审核注册。
{"title":"The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol","authors":"Alona Courtney ,&nbsp;Rachel O'Connell ,&nbsp;Tim Rattay ,&nbsp;Baek Kim ,&nbsp;Ramsey I. Cutress ,&nbsp;Cliona C. Kirwan ,&nbsp;Ashu Gandhi ,&nbsp;Patricia Fairbrother ,&nbsp;Nisha Sharma ,&nbsp;Christopher W.J. Cartlidge ,&nbsp;Kieran Horgan ,&nbsp;Stuart A. McIntosh ,&nbsp;Daniel R. Leff ,&nbsp;Raghavan Vidya ,&nbsp;Shelley Potter ,&nbsp;Chris Holcombe ,&nbsp;Ellen Copson ,&nbsp;Charlotte E. Coles ,&nbsp;Rajiv V. Dave","doi":"10.1016/j.isjp.2020.07.003","DOIUrl":"10.1016/j.isjp.2020.07.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Approximately 55,000 women in the United Kingdom are diagnosed with new breast cancer annually. Since emerging in December 2019, SARS-CoV-2 (coronavirus disease 2019, COVID-19) has become a global pandemic, affecting healthcare delivery worldwide. In response to the pandemic, multiple guidelines were issued to assist with rationalising breast cancer care. The primary aim of the B-MaP-C study is to audit and describe breast cancer management of patients newly diagnosed with breast cancer during the COVID-19 pandemic against pre-COVID-19 management practice in the UK. The implications of changes to management will be determined and the impact of a COVID-19 diagnosis on the patient’s breast cancer management will be determined.</p></div><div><h3>Methods and analysis</h3><p>This is a multi-centre collaborative audit of consecutive breast cancer patients undergoing treatment decisions during the acute and recovery phases of the COVID-19 pandemic. All patients with newly diagnosed primary breast cancer, whose treatment was decided in a multidisciplinary meeting from the 16th<!--> <!-->March 2020, are eligible for inclusion.</p></div><div><h3>Ethics and dissemination</h3><p>As this is an audit ethical approval is not required. Each participating centre is required to register the study locally and obtain local governance approvals prior to commencement of data collection. Local audit data will be available to individual participating units for governance purposes. The results of the data analysis will be submitted for publication, as well as disseminated via the ABS newsletter and a webinar. All data will be presented at national and international conferences, circumstances permitting.</p></div><div><h3>Registration details</h3><p>Each participating centre received local governance audit registration.</p></div>","PeriodicalId":42077,"journal":{"name":"International Journal of Surgery Protocols","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.isjp.2020.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38302944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
International Journal of Surgery Protocols
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1